Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jul 12 01:22PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-0.72 Insider Own55.09% Shs Outstand13.54M Perf Week-0.79%
Market Cap68.09M Forward P/E- EPS next Y-0.34 Insider Trans0.04% Shs Float6.10M Perf Month7.51%
Income-9.73M PEG- EPS next Q-0.16 Inst Own19.06% Short Float0.81% Perf Quarter0.80%
Sales49.22M P/S1.38 EPS this Y-93.14% Inst Trans-0.67% Short Ratio6.25 Perf Half Y-10.85%
Book/sh-0.15 P/B- EPS next Y46.03% ROA-30.91% Short Interest0.05M Perf Year-23.98%
Cash/sh0.33 P/C15.23 EPS next 5Y15.00% ROE-388.65% 52W Range4.50 - 7.32 Perf YTD-10.85%
Dividend Est.- P/FCF61.90 EPS past 5Y-24.83% ROI-222.15% 52W High-31.56% Beta0.49
Dividend TTM- Quick Ratio0.60 Sales past 5Y18.95% Gross Margin40.09% 52W Low11.33% ATR (14)0.18
Dividend Ex-Date- Current Ratio0.60 EPS Y/Y TTM-212.30% Oper. Margin-17.87% RSI (14)52.63 Volatility3.17% 3.58%
Employees230 Debt/Eq- Sales Y/Y TTM-8.29% Profit Margin-19.76% Recom3.00 Target Price6.00
Option/ShortYes / Yes LT Debt/Eq- EPS Q/Q-3.45% Payout- Rel Volume0.12 Prev Close5.00
Sales Surprise-11.11% EPS Surprise-166.67% Sales Q/Q-5.90% EarningsMar 12 AMC Avg Volume7.93K Price5.01
SMA200.24% SMA503.37% SMA200-7.70% Trades Volume673 Change0.20%
Date Action Analyst Rating Change Price Target Change
Nov-18-19Initiated The Benchmark Company Speculative Buy
Jul-11-24 04:05PM
Jun-04-24 09:00AM
Mar-19-24 08:28AM
Mar-12-24 04:30PM
Mar-07-24 09:00AM
04:35PM Loading…
Mar-06-24 04:35PM
Dec-14-23 08:22AM
Dec-12-23 09:54PM
Dec-04-23 04:30PM
Nov-02-23 08:30AM
Oct-17-23 08:30AM
Sep-13-23 04:00PM
Sep-11-23 04:00PM
Aug-22-23 08:30AM
08:45AM Loading…
Aug-01-23 08:45AM
Jul-24-23 04:00PM
Jul-20-23 04:00PM
Apr-17-23 08:30AM
Apr-05-23 09:50AM
Mar-15-23 03:50PM
Mar-13-23 08:30AM
Dec-16-22 08:48AM
Dec-13-22 04:00PM
Dec-09-22 04:30PM
Sep-08-22 04:00PM
Sep-06-22 04:00PM
Aug-15-22 08:08AM
Jul-23-22 09:57AM
Jul-21-22 04:00PM
04:00PM Loading…
Jul-14-22 04:00PM
Jun-13-22 06:30AM
May-31-22 08:30AM
May-03-22 08:30AM
May-02-22 01:16PM
Mar-15-22 04:45PM
Mar-11-22 08:30AM
Mar-07-22 01:10PM
Feb-15-22 08:30AM
Jan-20-22 08:30AM
Jan-04-22 08:30AM
Dec-13-21 04:20PM
Dec-06-21 09:20AM
Nov-05-21 08:24AM
Oct-20-21 10:25AM
Sep-13-21 04:00PM
Sep-06-21 03:00PM
Sep-02-21 04:30PM
Jul-26-21 08:30AM
Jul-22-21 08:00AM
Jul-14-21 08:30AM
Jul-08-21 03:06AM
Jun-15-21 09:00AM
Apr-29-21 03:31AM
Apr-16-21 12:00PM
Mar-16-21 10:52AM
Mar-15-21 02:13AM
Mar-11-21 04:00PM
Mar-05-21 08:30AM
Mar-04-21 12:30PM
Feb-22-21 09:00AM
Jan-29-21 12:24AM
Jan-19-21 09:00AM
Jan-05-21 08:30AM
Dec-15-20 12:22AM
Dec-14-20 04:00PM
Dec-07-20 04:00PM
Nov-16-20 04:40PM
Nov-11-20 09:00AM
Oct-31-20 10:08AM
Sep-16-20 07:27AM
Sep-14-20 04:00PM
Sep-08-20 04:30PM
Jul-30-20 07:21AM
Jul-27-20 04:01PM
Jul-22-20 08:00AM
Jul-15-20 03:55PM
Jun-17-20 09:37AM
May-27-20 07:05AM
Apr-28-20 09:50AM
Apr-27-20 07:20AM
Mar-28-20 09:23AM
Mar-16-20 09:35AM
Mar-12-20 04:17PM
Mar-10-20 08:30AM
Feb-26-20 09:32AM
Feb-18-20 05:44AM
Feb-05-20 09:23AM
Jan-29-20 09:00AM
Jan-17-20 09:34AM
Jan-13-20 06:07AM
Dec-24-19 09:37AM
Dec-16-19 04:00PM
Dec-09-19 08:30AM
Dec-08-19 08:59AM
Dec-04-19 08:36AM
Nov-14-19 08:53AM
Champions Oncology, Inc. engages in the development and sale of technology solutions and products to personalize the development and use of oncology drugs. Its technology platform, TumorGraft, is a novel approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company was founded by James M. Martell and David Sidransky on June 4, 1985 and is headquartered in Hackensack, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Mendelson Daniel NewmanDirectorJan 12 '24Buy6.501,0006,500198,625Jan 16 11:45 AM
Mendelson Daniel NewmanDirectorJan 11 '24Buy6.272,00012,540197,625Jan 12 12:47 PM
Mendelson Daniel NewmanDirectorJan 10 '24Buy6.312,94418,577195,625Jan 11 10:57 AM
Mendelson Daniel NewmanDirectorJan 09 '24Buy6.253,00018,750192,681Jan 10 08:57 AM
Mendelson Daniel NewmanDirectorJan 08 '24Buy6.151,0006,150189,681Jan 09 09:08 AM
Mendelson Daniel NewmanDirectorJan 05 '24Buy6.092,00012,180188,681Jan 08 03:11 PM
Mendelson Daniel NewmanDirectorJan 04 '24Buy6.123,00018,360186,681Jan 08 02:54 PM
Mendelson Daniel NewmanDirectorJan 03 '24Buy5.835002,915183,681Jan 04 01:37 PM
Mendelson Daniel NewmanDirectorDec 21 '23Buy4.922,50012,300183,181Dec 26 11:48 AM
Mendelson Daniel NewmanDirectorDec 20 '23Buy4.822,10010,122180,681Dec 21 02:31 PM
Mendelson Daniel NewmanDirectorDec 19 '23Buy4.755,00023,750178,581Dec 20 09:48 AM
ACKERMAN JOELDirectorOct 17 '23Option Exercise2.10114,552240,559856,997Jan 05 03:52 PM
Mendelson Daniel NewmanDirectorOct 11 '23Buy6.405,00032,000163,081Oct 13 12:48 PM
Mendelson Daniel NewmanDirectorOct 10 '23Buy6.411,1007,051158,081Oct 11 09:45 AM
Mendelson Daniel NewmanDirectorOct 06 '23Buy6.481,5309,914156,981Oct 10 10:02 AM
Mendelson Daniel NewmanDirectorOct 05 '23Buy6.472,00012,940155,451Oct 06 07:10 AM
Mendelson Daniel NewmanDirectorOct 04 '23Buy6.405,00032,000153,451Oct 04 05:30 PM
Mendelson Daniel NewmanDirectorOct 03 '23Buy6.302,50015,750148,451Oct 04 05:31 PM
Mendelson Daniel NewmanDirectorSep 29 '23Buy6.164,00024,640173,581Oct 16 09:53 AM
Mendelson Daniel NewmanDirectorSep 28 '23Buy6.225,00031,100169,581Oct 16 09:52 AM
Mendelson Daniel NewmanDirectorSep 27 '23Buy5.951,5008,925164,581Oct 16 09:51 AM
Mendelson Daniel NewmanDirectorSep 26 '23Buy5.655,00028,250145,951Sep 27 09:56 AM
Mendelson Daniel NewmanDirectorSep 22 '23Buy5.503,81220,966140,951Sep 25 02:59 PM
Mendelson Daniel NewmanDirectorSep 21 '23Buy5.515,00027,550137,139Sep 25 02:59 PM
Mendelson Daniel NewmanDirectorSep 20 '23Buy5.514,01822,139132,139Sep 25 02:59 PM
Mendelson Daniel NewmanDirectorSep 19 '23Buy5.285,00026,400128,121Sep 25 03:00 PM